DGL Group Limited (ASX:DGL – Get Rating) insider Simon Henry bought 54,500 shares of the stock in a transaction dated Wednesday, March 8th. The stock was purchased at an average cost of A$1.84 ($1.23) per share, with a total value of A$100,225.50 ($66,817.00).
DGL Group Stock Performance
The company has a current ratio of 2.09, a quick ratio of 0.94 and a debt-to-equity ratio of 46.25.
Get
DGL Group alerts:
DGL Group Company Profile
(Get Rating)
DGL Group Limited provides specialty chemical formulation and manufacturing, warehousing and distribution, and waste management and recycling solutions in Australia and New Zealand. The company operates through three segments: Chemical Manufacturing, Warehousing and Distribution, and Environmental Solutions.
See Also
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for DGL Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DGL Group and related companies with MarketBeat.com's FREE daily email newsletter.
DGL Group Limited(澳大利亞證券交易所代碼：DGL-GET Rating)內部人士西蒙·亨利在3月8日星期三的交易中購買了54,500股該股。這只股票是以每股1.84澳元(1.23美元)的平均成本購買的，總價值為100,225.50澳元(66,817.00美元)。
DGL集團股票表現
該公司的流動比率為2.09，速動比率為0.94，債務權益比率為46.25。
到達
DGL組警報：
DGL集團公司簡介
(獲取評級)
DGL集團有限公司在澳大利亞和紐西蘭提供特種化學品配方和製造、倉儲和分銷、廢物管理和回收解決方案。該公司通過三個部門運營：化學品製造、倉儲和分銷以及環境解決方案。
另請參閱
- 單克隆抗體?第三季度生物服務井噴式增長32%
- GitLab在指引上崩潰；分析師為其辯護
- 股息增加至少30年的醫療保健類股
- Coinbase流行，SVB化為灰燼
- 航空公司更新指引，股票前往不同目的地
接受DGL集團日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對DGL集團和相關公司的最新新聞和分析師評級的每日簡要摘要。
